Categorized | Business, Health, Local, People, Pottstown

Pottstown Physicians Now Affiliated With Penn Network

POTTSTOWN PA – Pinnacle ENT Associates, a Philadelphia area group of independent ear, nose, throat, allergy and audiology practices that includes the Pottstown office of Dr. Gerald Bell and Dr. Larry A. Feiner, said last week (March 1, 2013) it had become an affiliate of the Penn Medicine Ear, Nose and Throat Network.

Pinnacle, which is headquartered in Wayne PA, said it had been in discussions with Penn about creating a partnership to improve patient care, increase and standardize services, and lower costs. It is the only ear, nose and throat group in Pennsylvania recognized as a Penn network affiliate, it said.

Share

2 Responses to “Pottstown Physicians Now Affiliated With Penn Network”

Trackbacks/Pingbacks

  1. [...] Pottstown Physicians Now Affiliated With Penn Network Dr. Gerald Bell and Dr. Larry A. Feiner, whose Pottstown practice is part of Pinnacle ENT Associates, through it have joined a Penn Medicine network to expand patient care. [...]

  2. [...] Pottstown Physicians Now Affiliated With Penn Network Dr. Gerald Bell and Dr. Larry A. Feiner, whose Pottstown practice is part of Pinnacle ENT Associates, through it have joined a Penn Medicine network to expand patient care. [...]


From Our Sponsors

RSS Health News

  • New bird flu strain may be capable of spreading from human to human - study May 24, 2013
    HONG KONG (Reuters) - The H7N9 bird flu virus may be capable of spreading from human to human and can be transmitted not only through direct contact but also through airborne exposure, researchers at the University of Hong Kong have found. […]
  • Novo obesity drug could launch in U.S. end 2014 May 24, 2013
    COPENHAGEN (Reuters) - Danish drug maker Novo Nordisk said it could launch obesity treatment liraglutide in the United States by the end of next year and rejected some analysts' doubts over the medicine's commercial potential. […]
  • Aveo says partner Astellas will not seek EU nod for kidney cancer drug May 23, 2013
    (Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney cancer drug in Europe. […]
  • California reveals prices for health insurance under Obamacare May 23, 2013
    LOS ANGELES (Reuters) - California unveiled prices on Thursday that consumers will pay for a selection of health plans offered through the state under the Affordable Care Act, providing a glimpse into how health care reform may look as it is rolled out across the nation. […]
  • Lawmaker would give FDA more oversight of drug compounding May 23, 2013
    WASHINGTON (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority over drug compounding. […]
  • New J&J anti-depressant related to 'Special K' party drug May 23, 2013
    NEW BRUNSWICK, New Jersey (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard medications. […]
  • Sugar water injections may help ease knee pain May 23, 2013
    NEW YORK (Reuters Health) - Knee pain appears to decrease up to one year after "prolotherapy," a series of sugar water injections at the site of the pain, according to a new study. […]
  • Online tool reduces inappropriate medical tests May 23, 2013
    NEW YORK (Reuters Health) - A web-based decision-making tool that alerts heart doctors when diagnostic tests would not be useful for a specific patient can curb wasteful procedures, according to a new study. […]
  • Marijuana tied to better blood sugar control May 23, 2013
    NEW YORK (Reuters Health) - People who had used marijuana in the past month had smaller waists and lower levels of insulin resistance - a diabetes precursor - than those who never tried the drug, in a new study. […]
  • Labs reject dramatic findings on cancer drug in Alzheimer's mice May 23, 2013
    CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true. […]

The Posts On Health At Twitter